Treatment of chronic hepatitis with boceprevir leads to remission of porphyria cutanea tarda

Saved in:
Bibliographic Details
Published inBritish journal of dermatology (1951) Vol. 171; no. 6; pp. 1595 - 1596
Main Authors Aguilera, P., Laguno, M., To-Figueras, J.
Format Journal Article
LanguageEnglish
Published Oxford Blackwell Publishing Ltd 01.12.2014
Wiley-Blackwell
Subjects
Antiviral Agents - therapeutic use
Biological and medical sciences
Coinfection - complications
Dermatology
Drug Therapy, Combination
Errors of metabolism
Gastroenterology. Liver. Pancreas. Abdomen
Hepatitis C, Chronic - complications
Hepatitis C, Chronic - drug therapy
HIV Infections - complications
Humans
Liver. Biliary tract. Portal circulation. Exocrine pancreas
Male
Medical sciences
Metabolic diseases
Middle Aged
Other diseases. Semiology
Porphyria Cutanea Tarda - drug therapy
Proline - analogs & derivatives
Proline - therapeutic use
Proteins and glycoproteins
Remission Induction
Skin involvement in other diseases. Miscellaneous. General aspects
Photosensitivity
Skin disease
Dermatology
Metabolic diseases
Hepatic disease
Enzymopathy
Genetic disease
Hepatitis
Boceprevir
Chronic
Treatment
Porphyrin
Porphyria cutanea tarda
Pigments
Digestive diseases
Antiviral
Remission
Online AccessGet full text

Cover

More Information
Bibliography:ArticleID:BJD13376
istex:40FC90F699214E665A77D79B0878D61861CF39F0
ark:/67375/WNG-JFLX22C9-K
Conflicts of interest: none declared.
Funding sources: no external funding.
ISSN:0007-0963
1365-2133
DOI:10.1111/bjd.13376